PITTSBURGH, Oct. 4 /PRNewswire-FirstCall/ -- Mylan announced today that its Vice Chairman and CEO Robert J. Coury is scheduled to ring The Closing Bell(R) on the New York Stock Exchange (NYSE) at 4 p.m. today, Thursday, Oct. 4, 2007, in celebration of the Company’s acquisition of Merck Generics. Mylan announced on Tuesday, October 2, that it had completed its acquisition of Merck KGaA’s generics business to become one of the largest quality generics and specialty pharmaceuticals companies in the world.
A live webcast of The Closing Bell (beginning at 3:55 p.m.) will be available on the homepage of nyse.com.
About Mylan Inc.
Mylan Inc. is one of the world’s leading quality generic and specialty pharmaceutical companies. The company offers one of the industry’s broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Through its controlling interest in Matrix Laboratories Limited, Mylan has direct access to one of the largest active pharmaceutical ingredient (API) manufacturers in the world. Dey L.P., Mylan’s fully integrated specialty business, provides the company with innovative and diversified opportunities in the respiratory and allergy therapeutic areas. For more information about Mylan, please visit www.mylan.com.
CONTACT: Kris King of Mylan Laboratories Inc., +1-724-514-1800
Web site: http://www.mylan.com/
